Back to results
US 2014/0370046 A1Published application
Beta-glucan compounds, compositions, and methods
AssigneeBiothera, Inc.
InventorsNandita Bose, Anissa S.H. Chan, Michael E. Danielson, Mary A. Antonysamy, John P. Vasilakos, Keith B. Gorden, Steven M. Leonardo, William J. Grossman
Life of this patent
Estimating the term…
Abstract
Described herein are beta-glucan compounds, compositions, and methods. Generally, the methods exploit the observation that beta-glucan compounds can bind to B cells. Thus, the methods generally include administering a beta-glucan compound to a subject in an amount effective for the beta-glucan compound to bind to a B cell and modulate at least one biological function of the B cell.
Claims23
A method comprising:
- administering to a subject an amount of a β-glucan compound effective to bind to B cells and modulate at least one biological function of the B cells.
A β-glucan compound comprising:
- a β-glucan moiety coupled to an active moiety.
A pharmaceutical composition comprising:
- a β-glucan compound comprising a β-glucan moiety coupled to an active moiety.
Dependencies are inferred from the claim text.